Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium.
Bittencourt PL, Nardelli MJ, Barros LL, Cançado GGL, Cançado ELR, Terrabuio DRB, Villela-Nogueira CA, Ferraz MLG, Codes L, Rotman V, Rocco R, Felga GE, Dotta DD, Martins AS, Mendes LSC, da Silva MC, Hyppolito EB, Gomide GPM, Signorelli IV, de Oliveira MB, Ivantes CAP, Chindamo MC, de Almeida E Borges VF, Faria LC, Couto CA. Bittencourt PL, et al. Among authors: ivantes cap. Clin Transplant. 2024 Oct;38(10):e70002. doi: 10.1111/ctr.70002. Clin Transplant. 2024. PMID: 39436152
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: ivantes cap. Dig Dis Sci. 2022 Jul;67(7):3305-3312. doi: 10.1007/s10620-021-07122-y. Epub 2021 Jun 28. Dig Dis Sci. 2022. PMID: 34181166
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, Gomes NMF, de Oliveira EMG, Rotman V, de Oliveira MB, da Cunha SMCF, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: ivantes cap. Ann Hepatol. 2022 Jan-Feb;27(1):100546. doi: 10.1016/j.aohep.2021.100546. Epub 2021 Sep 30. Ann Hepatol. 2022. PMID: 34600142 Free article.
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH, Cançado GGL, Bittencourt PL, Couto CA, Guedes LV, Lima AMC, Ferraz MLG, Villela-Nogueira CA, Nardelli MJ, Faria LC, Gomes NMF, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Filho JG, Chagas AL, Terrabuio DRB, Cançado ELR; Members of the Brazilian Cholestasis Study Group Consortium. Braga MH, et al. Among authors: ivantes cap. Ann Hepatol. 2023 Jul-Aug;28(4):101105. doi: 10.1016/j.aohep.2023.101105. Epub 2023 Apr 23. Ann Hepatol. 2023. PMID: 37088418 Free article.
Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis.
Cançado GGL, Fucuta PDS, Gomes NMF, Couto CA, Cançado ELR, Terrabuio DRB, Villela-Nogueira CA, Braga MH, Nardelli MJ, Faria LC, Oliveira EMG, Rotman V, Oliveira MB, Cunha SMCFD, Silva MCD, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessôa MG, Signorelli IV, Coral GP, Bittencourt PL, Ferraz MLG. Cançado GGL, et al. Among authors: ivantes cap. Clin Res Hepatol Gastroenterol. 2024 Oct;48(8):102453. doi: 10.1016/j.clinre.2024.102453. Epub 2024 Aug 20. Clin Res Hepatol Gastroenterol. 2024. PMID: 39174006
Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
Cançado GGL, Couto CA, Terrabuio DRB, Cançado ELR, Villela-Nogueira CA, Ferraz MLG, Braga MH, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Guedes LV, Signorelli IV, Coral GP, Levy C, Bittencourt PL; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: ivantes cap. Dig Dis Sci. 2023 Feb;68(2):514-520. doi: 10.1007/s10620-022-07654-x. Epub 2022 Aug 22. Dig Dis Sci. 2023. PMID: 35989386
A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score.
Cançado GGL, Gomes NMF, Couto CA, Cançado ELR, Terrabuio DRB, Villela-Nogueira CA, Braga MH, Nardelli MJ, Faria LC, Oliveira EMG, Rotman V, Oliveira MB, Cunha SMCFD, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, Borges VFAE, Pace FHL, Pessôa MG, Signorelli IV, Coral GP, Bittencourt PL, Fucuta P, Filho RJC, Ferraz MLG. Cançado GGL, et al. Among authors: ivantes cap. Eur J Gastroenterol Hepatol. 2024 May 1;36(5):628-635. doi: 10.1097/MEG.0000000000002744. Epub 2024 Mar 25. Eur J Gastroenterol Hepatol. 2024. PMID: 38555601
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.
Lobato CMO, Codes L, Silva GF, Souza AFM, Coelho HSM, Pedroso MLA, Parise ER, Lima LMSTB, Borba LA, Evangelista AS, Rezende REF, Cheinquer H, Kuniyoshi ASO, Aires RS, Quintela EHD, Mendes LSC, Nascimento FCV, Medeiros Filho JEM, Ferraz MLCG, Abdala E, Bittencourt PL; Members of the Brazilian Real-Life Study about HCV treatment; Members of the Brazilian Real-Life Study about HCV treatment. Lobato CMO, et al. Ann Hepatol. 2019 Nov-Dec;18(6):849-854. doi: 10.1016/j.aohep.2019.08.001. Epub 2019 Aug 30. Ann Hepatol. 2019. PMID: 31537509 Free article.
National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.
Ferraz MLG, Piccoli LZ, Rezende R, Borba LA, Junior AP, Cheinquer H, Silva GF, Ferreira PRA, Villela-Nogueira CA, Mazo DF, Souza FF, Codes L, Ivantes CAP, Gomide GPM, Pereira GHS, Pessôa MG, França AVC, Pinto ADS, Teixeira R, Bittencourt PL. Ferraz MLG, et al. Among authors: ivantes cap. Braz J Infect Dis. 2022 Jul-Aug;26(4):102388. doi: 10.1016/j.bjid.2022.102388. Epub 2022 Jul 26. Braz J Infect Dis. 2022. PMID: 35905930 Free PMC article.
How are HCV-infected patients being identified in Brazil: a multicenter study.
Portari-Filho LH, Álvares-da-Silva MR, Gonzalez A, Ferreira AP, Villela-Nogueira CA, Mendes-Correa MC, Lima JM, Lopes EP, Brandão CE, Ivantes C, Lyra A, Lindenberg A, Ferraz ML. Portari-Filho LH, et al. Braz J Infect Dis. 2019 Jan-Feb;23(1):34-39. doi: 10.1016/j.bjid.2019.01.006. Epub 2019 Mar 6. Braz J Infect Dis. 2019. PMID: 30849332 Free PMC article.
38 results